Recordati Netherlands B.V.
3 products tracked · names used in filings: Recordati Netherlands B.V.
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Fotivda tivozanib hydrochloride monohydrate | Authorised | 2017-08-24 |
| 🇪🇺 | Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron) dinutuximab beta | Authorised | 2017-05-08 |
| 🇪🇺 | Sylvant siltuximab | Authorised | 2014-05-22 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.